Global Adme Toxicology Testing Market Insights 2024, Forecast To 2033
8 Mar, 2024
The ADME toxicology testing market has grown rapidly, increasing from $9.3 billion in 2023 to $10.34 billion in 2024, with a CAGR of 11.2%. This growth is attributed to factors such as stringent regulatory requirements and advancements in in vitro testing methods. Moving forward, the market is expected to see rapid growth, reaching $15.77 billion in 2028, with a CAGR of 11.1%. Factors such as the rapid expansion of biopharmaceuticals and growing emphasis on personalized medicine will drive this growth.
Global ADME Toxicology Testing Market Key Driver
The rising demand for novel drugs, as evidenced by the approval of 53 novel drugs in 2022 compared to 50 in the previous year by the US Food and Drug Administration, is expected to drive the growth of the ADME toxicology testing market. ADME toxicity testing plays a crucial role in drug development to ensure the safety of these pharmaceutical substances, which have not been previously approved or marketed for therapeutic use, by assessing their potential to produce harmful toxins in the body.
Get A Free Sample Of The Global ADME Toxicology Testing Market ReportGlobal ADME Toxicology Testing Market Segments
The adme toxicology testing market covered in this report is segmented –
1) Product Type:Instruments, Software Solutions, Assays Systems, Reagents, Other Products
2) Method:Cellular Assay, Biochemical Assay, In Silica, Ex-vivo
3) Technology:Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies
4) Application:Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications
5) End-User:Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users
By Geography: The countries covered in the adme toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the ADME toxicology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major ADME Toxicology Testing Industry Players
AbbVie Inc.; Thermo Fisher Scientific Inc.; Boehringer Ingelheim GmbH; Laboratory Corporation of America Holdings; Corning Incorporated; Eurofins Scientific SE; Agilent Technologies Inc.; Lonza Group AG; Dassault Systèmes SE; Catalent Inc.; Charles River Laboratories International Inc.; Beckman Coulter Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Curia Global Inc; Promega Corporation; Takara Bio Inc; AB Sciex LLC; QPS Holdings LLC; Simulations Plus Inc.; Cyprotex; XenoTech LLC; BioIVT LLC; Absorption Systems; Creative Bioarray; SOLVO Biotechnology Rt.; Creative Biolabs Inc; Gentronix Limited; Admecell Inc.; Molecular Discovery Ltd.
Get The Full Global ADME Toxicology Testing Market Report
ADME Toxicology Testing Market Overview
ADME toxicology testing is a set of studies conducted to assess the potential toxicity of a substance or drug candidate based on its absorption, distribution, metabolism, and excretion (ADME) properties. These tests are used in drug development to ensure the well-being of individuals exposed to substances.